Skip to main content
. Author manuscript; available in PMC: 2022 Sep 1.
Published in final edited form as: J Rheumatol. 2021 Feb 15;48(9):1410–1416. doi: 10.3899/jrheum.201199

Table 1.

Baseline characteristics of patients with psoriatic arthritis (PsA) with delay in diagnosis of 2 or less years compared to more than 2 years

≤2yr (n=73) >2yr (n=89) Total (n=162) p value
Years from PsA symptom onset to Physician/Rheumatologist diagnosis of PsA, median (IQR) 0.5 (0.2–1.0) 6.5 (3.5–10.1) 2.5 (0.5–7.3) --
Age (yrs) at PsA symptom onset, mean (SD) 44.0 (12.4) 39.5 (12.4) 41.5 (12.6) 0.041
Sex, female (%) 36 (49%) 39 (44%) 75 (46%) 0.48
Education Level 0.79
 High school or less 16 (22%) 16 (18%) 32 (20%)
 Some college or 2yr degree 27 (38%) 36 (40%) 63 (39%)
 ≥4 yr college degree 29 (40%) 37 (42%) 66 (41%)
 Missing 1 0 1
Race 0.018
 Black 2 (3%) 2 (2%) 4 (2%)
 Asian 0 (0%) 8 (9%) 8 (5%)
 Hispanic 6 (8%) 3 (3%) 9 (6%)
 Other/Mixed 1 (1%) 0 (0%) 1 (1%)
 White 64 (88%) 75 (85%) 139 (86%)
 Unknown 0 1 1
BMI (kg/m2) at PsA diagnosis, mean (SD) 29.5 (6.1) 32.2 (7.7) 31.0 (7.1) 0.028
 Missing 4 5 9
Smoking at PsA diagnosis 0.53
 Current smoker 12 (16%) 15 (17%) 27 (17%)
 Past smoker 23 (32%) 35 (39%) 58 (36%)
 Never smoker 38 (52%) 39 (44%) 77 (48%)
Alcohol intake at PsA dx 56 (77%) 65 (73%) 121 (75%) 0.59
Psoriasis (Current or personal history) 0.15
 No psoriasis 2 (3%) 5 (6%) 7 (4%)
 Current psoriasis 70 (96%) 78 (88%) 148 (91%)
 Personal history of psoriasis 1 (1%) 6 (7%) 7 (4%)
Family history of psoriasis 24 (40%) 35 (49%) 59 (45%) 0.32
 Missing 13 17 30
Estmated age (yrs) at onset of psoriasis symptom, mean (SD) 34 (14) 34 (15) 34 (14) 0.85
 Missing 2 5 7
Psoriasis Severity at first diagnosis 0.25
 Mild (< 2% BSA) 38 (54%) 34 (41%) 72 (47%)
 Moderate (2–10% BSA) 20 (28%) 33 (40%) 53 (34%)
 Severe (>10% BSA) 13 (18%) 16 (19%) 29 (19%)
 No Documentation/Missing 2 6 8
Type of psoriasis at first dx 0.033
 Chronic plaque psoriasis 56 (80%) 74 (88%) 130 (84%)
 Guttate psoriasis 3 (4%) 1 (1%) 4 (3%)
 Pustular psoriasis- Generalized 1 (1%) 0 (0%) 1 (1%)
 Pustular psoriasis- palms/soles 2 (3%) 4 (5%) 6 (4%)
 Sebo-psoriasis 5 (7%) 0 (0%) 5 (3%)
 Chronic plaque psoriasis & Guttate psoriasis 0 (0%) 3 (4%) 3 (2%)
 Chronic plaque & Pustular psoriasis-palms/soles 1 (1%) 0 (0%) 1 (1%)
 Chronic plaque & Sebo-psoriasis 2 (3%) 2 (2%) 4 (3%)
 No Documentation/Missing 3 5 8
Site of psoriatic lesions at first diagnosis of psoriasis 0.65
 Palms and/or soles 1 (5%) 3 (15%) 4 (10%)
 Elbows and/or knees 3 (14%) 4 (20%) 7 (17%)
 Limbs arms and/or legs 5 (23%) 5 (25%) 10 (24%)
 Trunk 0 (0%) 1 (5%) 1 (2%)
 Face 1 (5%) 0 (0%) 1 (2%)
 Scalp 9 (41%) 7 (35%) 16 (38%)
 Intergluteal/Perianal 2 (9%) 0 (0%) 2 (5%)
 Genital 1 (5%) 0 (0%) 1 (2%)
 Missing 51 69 120
Nail involvement at first diagnosis of psoriasis 24 (42%) 23 (35%) 47 (38%) 0.41
 No documentation 16 23 39
Family history of PsA 6 (12%) 6 (11%) 12 (11%) 0.84
 Missing 22 32 54
Enthesitis at or prior to PsA diagnosis 16 (22%) 35 (39%) 51 (31%) 0.018
Dactylitis at or prior to PsA diagnosis 35 (48%) 35 (39%) 70 (43%) 0.27
Inflammatory back pain at or prior to PsA diagnosis 4 (5%) 13 (15%) 17 (10%) 0.059
Uveitis 4 (5%) 3 (3%) 7 (4%) 0.70
Inflammatory bowel disease 0 (0%) 0 (0%) 0 (0%) --
ESR (mm/hr) at PsA diagnosis, mean (SD) 18.9 (18.3) 18.2 (15.3) 18.5 (16.8) 0.95
 Missing 4 17 21
CRP (mg/L) at PsA diagnosis, mean (SD) 16.5 (32.4) 13.6 (19.0) 14.9 (26.0) 0.87
 Missing 22 29 51
Radiographic damage 17 (24%) 31 (35%) 48 (30%) 0.12
 Missing 1 0 1